Gene therapy for arthritis - Where do we stand?

Arthritis Research and Therapy

Volumn 7, Issue 6, 2005, Pages 227-229

  Chernajovsky, Yuti ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ETANERCEPT; IMMUNOGLOBULIN; INFLIXIMAB; PARVOVIRUS VECTOR; RETROVIRUS VECTOR; TUMOR NECROSIS FACTOR ANTIBODY;

ARTHRITIS; CLINICAL TRIAL; COST CONTROL; DRUG COST; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; DRUG WITHDRAWAL; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HUMAN; NONHUMAN; NOTE; PSORIATIC ARTHRITIS; RELAPSE; REMISSION; RHEUMATOID ARTHRITIS; SPONDYLITIS; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; GENE THERAPY; HUMANS; SPONDYLARTHRITIS;

EID: 27844569864     PISSN: 14786354     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar1823     Document Type: Note

References (22)

1. Chemajovsky Y, Gould D, Podhajcer O: Gene therapy for autoimmune diseases: quo vadis? Nat Rev Immunol 2004, 4: 800-811.
2. Chernajovsky Y, Vessillier S, Adams G, Gofur Y, Subang MC, Annenkov A, Favorov P, Daly GM, Gould DJ: Development of new molecules, vectors and cells for therapy of arthritis. Joint Bone Spine 2003,70:474-476.
3. Evans CH: Gene therapy: what have we accomplished and where do we go from here? J Rheumatol 2005, 32:17-20.
4. Robbins PD, Evans CH, Chernajovsky Y: Gene therapy for arthritis. Gene Ther 2003, 10:902-911.
5. van de Loo F, Smeets R, van den Berg W: Gene therapy in animal models of rheumatoid arthritis: are we ready for the patients? Arthritis Res Ther 2004, 6:183-196.
6. Breedveld FC, Emery P, Keystone E, Patel K, Furst DE, Kalden JR, St Clair EW, Weisman M, Smolen J, Lipsky PE, et al.: Infliximab in active early rheumatoid arthritis. Ann Rheum Dis 2004, 63: 149-155.
7. Emery P, Seto Y: Role of biologics in early arthritis. Clin Exp Rheumatol 2003, 21:S191-S194.
8. Mpofu S, Fatima F, Moots RJ: Anti-TNF-alpha therapies: they are all the same (aren't they?). Rheumatology (Oxford) 2005, 44:271-273.
9. Evans CH, Robbins PD, Ghivizzani SC, Wasko MC, Tomaino MM, Kang R, Muzzonigro TA, Vogt M, Elder EM, Whiteside TL, et al.: Gene transfer to human joints: progress toward a gene therapy of arthritis. Proc Nat/ Acad Sci USA 2005, 102:8698-8703.
10. Vessillier S, Adams G, Chernajovsky Y: Latent cytokines: development of novel cleavage sites and kinetic analysis of their differential sensitivity to MMP-1 and MMP-3. Protein Eng Des Sel 2004, 17:829-835.
11. Adams G, Vessillier S, Dreja H, Chernajovsky Y: Targeting cytokines to inflammation sites. Nat Biotechnol 2003, 21: 1314-1320.
12. Lode HN, Xiang R, Becker JC, Gillies SD, Reisfeld RA: Immunocytokines: a promising approach to cancer immunotherapy. Pharmacol Ther 1998, 80:277-292.
13. Nissim A, Gofur Y, Vessillier S, Adams G, Chernajovsky Y: Methods for targeting biologicals to disease sites. Trends Mol Med 2004, 10:269-274.
14. Jorgensen C, Noel D, Apparailly F, Sany J: Stem cells for repair of cartilage and bone: the next challenge in osteoarthritis and rheumatoid arthritis. Ann Rheum Dis 2001, 60:305-309.
15. van der Kraan P, van de Loo F, van den Berg W: Role of gene therapy in tissue engineering procedures in rheumatology: the use of animal models. Biomaterials 2004, 25:1497-1504.
16. Lewis DL, Wolff JA: Delivery of siRNA and siRNA expression constructs to adult mammals by hydrodynamic intravascular injection. Methods Enzymol 2005, 392:336-350.
17. Wells DJ: Opening the floodgates: clinically applicable hydrodynamic delivery of plasmid DNA to skeletal muscle. Mol Ther 2004, 10:207-208.
18. Gould DJ, Favorov P: Vectors for the treatment of autoimmune disease. Gene Ther 2003, 10:912-927.
19. Chernajovsky Y, Adams G, Podhajcer OL, Mueller GM, Robbins PD, Feldmann M: Inhibition of transfer of collagen-induced arthritis into SCID mice by ex vivo infection of spleen cells with retroviruses expressing soluble tumor necrosis factor receptor. Gene Ther 1995, 2:731-735.
20. Annenkov A, Chernajovsky Y: Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zeta. Gene Ther 2000, 7:714-722.
21. Nakajima A, Seroogy CM, Sandora MR, Tamer IH, Costa GL, Taylor-Edwards C, Bachmann MH, Contag CH, Fathman CG: Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. J Clin Invest 2001, 107:1293-1301.
22. Apparailly F, Millet V, Noel D, Jacquet C, Sany J, Jorgensen C: Tetracycline-inducible interieukin-10 gene transfer mediated by an adeno-associated virus: application to experimental arthritis. Hum Gene Ther 2002, 13:1179-1188.